UK Coronavirus Cancer Monitoring Project FAQ Page

The UK Coronavirus cancer monitoring scheme is a clinician-led reporting project supported to enable tracking of cancer patients who have tested positive for COVID-19 across the United Kingdom.

The aims of this project are to ensure adequate cancer care is being delivered where required across the country and to assess the impact on cancer patients. The project collects information about prevalence of COVID-19 infections with associated anonymised data about site of disease and mortality through our COVID-19 response reporting network.

It is unique in providing the first example of Live Clinical Data Dissemination System during this pandemic. This enables direct real-time daily updates back to individual Cancer Centres. This system is coordinated by the Centre for Computational Biology allowing annotation, analysis and dissemination securely through a dedicated workflow hosted by the Compute and Storage for Life Science (CaStLeS) infrastructure as part of the Birmingham Environment for Academic Research local Cloud (BEARCloud). A pushed near-real-time update is generated daily to an interactive website and reports are sent to individual UK Cancer Centres and clinicians at a weekly basis.

The project is being co-led by Prof Gary Middleton (University Hospitals Birmingham), Prof Rachel Kerr (Oxford University Hospitals) and Dr Lennard Lee (University Hospitals Birmingham). Senior scientific Lead is Professor Jean-Baptiste Cazier (University of Birmingham) with further scientific leadership supported provided by Dr Claire Palles, Dr Roland Arnold and Shivan Sivakumar.


See FAQs on